Tactile Systems Technology Inc. (TCMD) carries a Roarable Rating of C+ (Hold) with 67/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
As of 2026-11-03, Tactile Systems Technology Inc. (NASDAQ: TCMD) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 67/100 at a spot price of $23.04 (-5.22% 1D, market cap $521.9M). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, TCMD ranks #110 in composite RQD confidence.
Within the Health Care sector (Medical/Dental Instruments), TCMD carries a Roarable C+ (67/100 RQD), trailing P/E of 28.9x, gross margin of 75.9%, and ROIC of 17.1%. By comparison, SGHT (Sight Sciences Inc.) holds a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $513.4M) and ANGO (AngioDynamics Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -23.4%, cap $504.2M). Among the 5-stock peer group, TCMD leads on earnings multiple (28.9x) while TCMD leads on capital efficiency (17.1% ROIC).
Per TCMD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001027838), Tactile Systems Technology Inc. generated $329.5M in revenue (+12.5% YoY), $19.1M in net income, and $40.4M in free cash flow against $273.9M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (76% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 8.38 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9
SEC XBRL FY 2025 (10-K): 12.3% FCF Margin ($40.4M FCF) & 75.9% Gross Margin
Put hedging (50% put share) caps near-term gamma upside (-13 pts vs max)
Even with a 67/100 (C+) score, TCMD faces multiple-compression risk if 28.9x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 73.4% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($22.74) or 200D SMA ($25.80) invalidates the momentum regime and cuts Target Base ($23.97) toward Bear Floor ($18.70).
Tactile Systems Technology Inc. (TCMD) dropped -5.22% to $23.04, trading at 34% of its 52-week range ($15.32 – $37.77). Solid 76% profit margin (17% return on capital), mixed timing at 29x P/E—hold if owned, no rush to chase.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
ad-hoc-news.de report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
Tactile Systems Technology (NASDAQ:TCMD), which operates as Tactile Medical, reported third-quarter revenue of $91.9 million, up 7.1% from a year earlier, as continued double-digit growth in its lymphedema business offse
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of +3.33% and -1.05%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +12.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on TCMD today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for TCMD. Explore sector supply chains on /butterfly.
Across 1016 tracked Health Care securities in the Roarable RQD universe, Tactile Systems Technology Inc. (TCMD) ranks #110 by composite RQD confidence (67/100, grade C+) and #432 by equity capitalization ($521.9M). Within this direct 5-issuer industry benchmark cohort, TCMD leads on earnings valuation at 28.9x trailing P/E, while TCMD leads on capital efficiency and profitability with 17.1% ROIC and 75.9% gross margin. TCMD currently leads its immediate peer cohort in composite quantitative strength at 67/100 (C+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| TCMD
ACTIVE
Tactile Systems Technology Inc. | C+ | 67/100 | 28.9x | 75.9% | 17.1% | -5.22% | $521.9M | Benchmark Subject |
| SGHT Sight Sciences Inc. | D- | 39/100 | — | 86.2% | -35.0% | -2.61% | $513.4M | /sght-vs-tcmd → |
| ANGO AngioDynamics Inc. | D- | 36/100 | — | 54.6% | -23.4% | -2.91% | $504.2M | /ango-vs-tcmd → |
| SENS Senseonics Holdings Inc. | D- | 40/100 | — | 44.7% | -35.0% | -2.46% | $502.8M | /sens-vs-tcmd → |
| DCTH Delcath Systems Inc. | C- | 59/100 | — | 86.2% | 0.8% | -4.10% | $487.2M | /dcth-vs-tcmd → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Tactile Systems Technology Inc. (TCMD) reported GAAP revenue of $329.5M (+12.5% vs. FY2024 revenue of $293.0M , and +20.1% cumulative change since FY2023) , GAAP net income of $19.1M, operating cash flow of $42.8M, and free cash flow of $40.4M (+5.7% YoY). On the balance sheet, TCMD closed FY2025 with $273.9M in total assets against $0 in total debt (Altman Z-Score: 8.38, Piotroski F-Score: 8/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $329.5M | $19.1M | $42.8M | $40.4M | $273.9M | — |
| FY2024 (FY) | 2024-12-31 | $293.0M | $17.0M | $40.7M | $38.3M | $297.9M | — |
| FY2023 (FY) | 2023-12-31 | $274.4M | $28.5M | $35.9M | $35.9M | — | — |
As of 2026-11-03, Tactile Systems Technology Inc. (NASDAQ: TCMD) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 67/100 at a spot price of $23.04 (-5.22% 1D, market cap $521.9M). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, TCMD ranks #110 in composite RQD confidence.
Within the Health Care sector (Medical/Dental Instruments), TCMD carries a Roarable C+ (67/100 RQD), trailing P/E of 28.9x, gross margin of 75.9%, and ROIC of 17.1%. By comparison, SGHT (Sight Sciences Inc.) holds a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $513.4M) and ANGO (AngioDynamics Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -23.4%, cap $504.2M). Among the 5-stock peer group, TCMD leads on earnings multiple (28.9x) while TCMD leads on capital efficiency (17.1% ROIC).
Per TCMD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001027838), Tactile Systems Technology Inc. generated $329.5M in revenue (+12.5% YoY), $19.1M in net income, and $40.4M in free cash flow against $273.9M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (76% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
TCMD last traded at $23.04 (-5.22% on volume of 210,733 shares), positioning the stock +1.32% above its 50-day simple moving average ($22.74) and -10.70% below its 200-day simple moving average ($25.80). Across its 52-week range of $15.32 to $37.77, TCMD sits at the 34.4% percentile with a 14-day RSI of 48.9 (NEUTRAL RANGE) and an implied next-earnings move of ±6.3% ($21.59 to $24.49).
Why TCMD Stock dropped -5.22% Today — RQD Quant Desk Flash. Solid 76% profit margin (17% return on capital), mixed timing at 29x P/E—hold if owned, no rush to chase.
Per the Roarable RQD rating, TCMD scores 70 out of 100 (letter grade B-; verdict "Roarable Buy — Sound Institutional Accumulation"). The five pillars are:
Taken together, the rating points to a financially sound company with strong cash economics and balance-sheet quality, paired with only moderate macro and institutional-flow support. Valuation tradeoffs are visible in the market data: trailing P/E of 28.9 versus forward P/E of 24.3 implies expected earnings growth in the source's framing, while EV/EBITDA of 14.9 is a premium-style multiple to weigh against the cash-yield metrics. The 52-week range of $14.84 – $37.77 shows the stock has moved widely, so the current price of 24.31 sits in the middle of that span. This brief is analytical and educational, not personalized advice.
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $329.5M | $29.3M | $19.1M | N/A | $40.4M | $83.4M | N/A |
| FY 2024 | $293.0M | $22.2M | $17.0M | N/A | $38.3M | $94.4M | N/A |
| FY 2023 | $274.4M | $18.0M | $28.5M | N/A | $35.9M | N/A | N/A |
Per the SEC financials, revenue rose from $274.4M (FY 2023) to $293.0M (FY 2024) to $329.5M (FY 2025). Operating income moved from $18.0M to $22.2M to $29.3M over the same span. The market data reports gross margin of 75.9%, operating margin of 8.9%, and net margin of 5.8%, with ROIC of 17.1%. Per the Roarable RQD rating, the Altman Z-Score is 8.38 and the Piotroski F-Score is 8/9, with Debt/Equity of 0.5. Cash declined from $94.4M to $83.4M across FY 2024–FY 2025 per the SEC financials.
Real-time company headlines, analyst actions, and sector developments for Tactile Systems Technology Inc. (TCMD) • Click "Debate This Headline" to argue it in the Roar Pit below
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
ad-hoc-news.de report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Tactile Systems Technology Inc. (TCMD) market action, institutional positioning, and fundamental catalysts.
Welcome to the TCMD (Tactile Systems Technology Inc.) Roar Pit. Current RQD Composite is 70/100 (Roarable Buy — Sound Institutional Accumulation) in Medical/Dental Instruments. Bulls point to capital efficiency (17.1% ROIC), while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Everyone in here is repeating the bull case on TCMD, but look at what you are paying: 28.9x trailing P/E with 75.9% gross margins. Unless Tactile Systems Technology Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
Looking at the 5-pillar RQD breakdown on TCMD, the market is fixating on short-term headline noise in Medical/Dental Instruments and ignoring the balance sheet and cash flow trajectory. At $24.31 (52-wk range $14.84 - $37.77), any beat on forward guidance forces shorts and underweight funds to chase.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).